Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I think so! August Numbers to be announced!
VERY THIN...........AGAIN! We just need a few ask taps!
MPID ASK PRICE SIZE TIME
ETRF 0.0475 38,360 10:21
CSTI 0.0489 94,000 09:30
CDEL 0.049 25,000 10:17
GTSM 0.0506 10,000 09/16
NITE 0.0695 15,000 09:30
Good Post!
RXMD seeks to define a new level of service and healthcare that is driven by the needs of patients and families. As the healthcare system changes and adjusts, gaps form in the delivery of care leaving patients, providers, and even payors behind to deal with negative health outcomes. RXMD works to eliminate obstacles and inadequacies in care by delivering innovative, patient-centric services that improve the health and well-being of our communities.
5 more minutes to hit 5's today!
Completely Undervalued Here!!!!
Again.....................this is not true.
This is holding up nicely today! Strong Stock......
$RXMD - Progressive Care Issues Corporate Update
BY GlobeNewswire
— 8:00 AM ET 09/16/2020
MIAMI, FL, Sept. 16, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Progressive Care Inc. ( RXMD
Loading...
Loading...
) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to provide current and prospective shareholders with an update on the hiring process for its new CEO and its acquisition of MyApps Corp. (“MyApps”) (myapps.solutions), a leading developer of healthcare software, which includes the emerging telehealth service app, CallingDr™ (callingdr.com).
New CEO Process
The Company is also now in advanced discussions regarding the hiring of a new Chief Executive Officer with the experience and skill set to take Progressive Care ( RXMD
Loading...
Loading...
) to the next level. The Company is focused on installing a CEO able to drive financial strength, cultivate constructive communication with the business and investment community, and reinforce core values, with the ultimate goals of uplisting to a major exchange and taking the Company to over $100 million in sales.
“We expect revenues of more than $40 million in 2020 at this point, given our growth rate and what we have accomplished so far this year,” noted Alan Jay Weisberg, interim CEO and Chairman of the Board at Progressive Care ( RXMD
Loading...
Loading...
). “Several years ago, when our revenue was $15 million, we saw our path to $40 million in sales and described this to our shareholders. Now, we are running at over $40 million on the top line and see a path to $100 million and beyond as a basic extrapolation of our organic growth curve paired with our strategic agenda, which provides for an open run to serve all 50 states in prescriptions and data management, capitalize on strong deregulatory tailwinds. We are deep in the process of establishing this new leadership, and we have strong reason to believe we will have an exceptional executive team in place, with the experience, skills, and drive to foster that next step, very soon.”
MyApps Acquisition
As announced in its release dated September 8, Progressive Care ( RXMD
Loading...
Loading...
) is in the process of acquiring MyApps, a leading commercial-stage app developer that has full control over CallingDr, a complete telehealth platform providing multiple levels of service with a suite of products currently in use in single-physician clinics, multi-physician clinics, emergency room centers, nursing homes, and home health setups across multiple US states. While working towards the completion of the acquisition, Progressive Care ( RXMD
Loading...
Loading...
) will be taking necessary regulatory steps to participate in the prescription drug business in all 50 US states (the Company is currently licensed in 14 US states) on a mail-order basis. In-house Company research suggests that nearly one-third of all prescriptions in the US are filled on a mail-order basis, suggesting that this transition will increase Progressive Care’s total addressable market by over $200 billion (based on Company data along with data from the US Department of Health and Human Services).
According to information from MyApps management, MyApps serviced 3,448 new patients over the six months between March 1 and September 1, 2020, with some having multiple sessions, amounting to over 10,500 remote healthcare sessions in the past six months.
Along with CallingDr™, MyApps also has a portal named FindingDr™, which helps providers connect with new patients. Following the closing of the acquisition, Progressive Care ( RXMD
Loading...
Loading...
) will be able to offer healthcare providers across the country and in its network of business with access to this portal to connect them with new patients.
Weisberg added, “GoodRX, which is comparable to a stock in the pharmacy services space, recently filed for an IPO with a pre-IPO valuation of $2.8 billion on under $390 million in 2019 sales, trading at nearly 7 times trailing sales. The 2019 acquisition of ‘HeyDoctor’ appears to be an important part of its growth plan and future valuation. Pairing pharmacy services with a powerful telehealth platform unlocked the prospect of fresh growth potential relative to the space, especially as federal and state regulations on telemedicine were stripped from the equation after the onset of the COVID-19 pandemic health crisis in March. We believe CallingDr is a superior telemedicine platform. We also believe we have an even more potent mix of assets that present a similar formula for powering shareholder value over the coming decade. Yet, Progressive Care ( RXMD
Loading...
Loading...
) shares trade under 0.5 times 2019 sales. I believe that our valuation has been greatly impacted by recent trading volume, which is not a result of insider selling. With enormous year-over-year growth, a coming $200 billion expansion in total addressable market, and the acquisition and integration of an active cutting-edge telehealth platform with a national customer footprint already established, and with the goal of uplisting to a major exchange, Progressive Care ( RXMD
Loading...
Loading...
) continues to aggressively strive toward leadership as an innovative technology and personalized healthcare company.”
Management also notes that, according to a recent report by Fortune Business Insights, the global telemedicine market is projected to grow from $34.28 billion in 2018 to $185.66 billion by 2026, exhibiting a CAGR of 23.5% over that period. Another report from Global Market Insights notes that nearly half of this overall market size and growth is attributable to activity within the US market alone. According to multiple market research publications, the mail-order prescription market is growing nearly twice as fast as any other segment of the prescription drug market.
For more information about Progressive Care ( RXMD
Loading...
Loading...
), please visit our website.
Connect and stay in touch with us on social media:
Progressive Care Inc. ( RXMD
Loading...
Loading...
)
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
$RXMD - Progressive Care Issues Corporate Update
BY GlobeNewswire
— 8:00 AM ET 09/16/2020
MIAMI, FL, Sept. 16, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Progressive Care Inc. ( RXMD
Loading...
Loading...
) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to provide current and prospective shareholders with an update on the hiring process for its new CEO and its acquisition of MyApps Corp. (“MyApps”) (myapps.solutions), a leading developer of healthcare software, which includes the emerging telehealth service app, CallingDr™ (callingdr.com).
New CEO Process
The Company is also now in advanced discussions regarding the hiring of a new Chief Executive Officer with the experience and skill set to take Progressive Care ( RXMD
Loading...
Loading...
) to the next level. The Company is focused on installing a CEO able to drive financial strength, cultivate constructive communication with the business and investment community, and reinforce core values, with the ultimate goals of uplisting to a major exchange and taking the Company to over $100 million in sales.
“We expect revenues of more than $40 million in 2020 at this point, given our growth rate and what we have accomplished so far this year,” noted Alan Jay Weisberg, interim CEO and Chairman of the Board at Progressive Care ( RXMD
Loading...
Loading...
). “Several years ago, when our revenue was $15 million, we saw our path to $40 million in sales and described this to our shareholders. Now, we are running at over $40 million on the top line and see a path to $100 million and beyond as a basic extrapolation of our organic growth curve paired with our strategic agenda, which provides for an open run to serve all 50 states in prescriptions and data management, capitalize on strong deregulatory tailwinds. We are deep in the process of establishing this new leadership, and we have strong reason to believe we will have an exceptional executive team in place, with the experience, skills, and drive to foster that next step, very soon.”
MyApps Acquisition
As announced in its release dated September 8, Progressive Care ( RXMD
Loading...
Loading...
) is in the process of acquiring MyApps, a leading commercial-stage app developer that has full control over CallingDr, a complete telehealth platform providing multiple levels of service with a suite of products currently in use in single-physician clinics, multi-physician clinics, emergency room centers, nursing homes, and home health setups across multiple US states. While working towards the completion of the acquisition, Progressive Care ( RXMD
Loading...
Loading...
) will be taking necessary regulatory steps to participate in the prescription drug business in all 50 US states (the Company is currently licensed in 14 US states) on a mail-order basis. In-house Company research suggests that nearly one-third of all prescriptions in the US are filled on a mail-order basis, suggesting that this transition will increase Progressive Care’s total addressable market by over $200 billion (based on Company data along with data from the US Department of Health and Human Services).
According to information from MyApps management, MyApps serviced 3,448 new patients over the six months between March 1 and September 1, 2020, with some having multiple sessions, amounting to over 10,500 remote healthcare sessions in the past six months.
Along with CallingDr™, MyApps also has a portal named FindingDr™, which helps providers connect with new patients. Following the closing of the acquisition, Progressive Care ( RXMD
Loading...
Loading...
) will be able to offer healthcare providers across the country and in its network of business with access to this portal to connect them with new patients.
Weisberg added, “GoodRX, which is comparable to a stock in the pharmacy services space, recently filed for an IPO with a pre-IPO valuation of $2.8 billion on under $390 million in 2019 sales, trading at nearly 7 times trailing sales. The 2019 acquisition of ‘HeyDoctor’ appears to be an important part of its growth plan and future valuation. Pairing pharmacy services with a powerful telehealth platform unlocked the prospect of fresh growth potential relative to the space, especially as federal and state regulations on telemedicine were stripped from the equation after the onset of the COVID-19 pandemic health crisis in March. We believe CallingDr is a superior telemedicine platform. We also believe we have an even more potent mix of assets that present a similar formula for powering shareholder value over the coming decade. Yet, Progressive Care ( RXMD
Loading...
Loading...
) shares trade under 0.5 times 2019 sales. I believe that our valuation has been greatly impacted by recent trading volume, which is not a result of insider selling. With enormous year-over-year growth, a coming $200 billion expansion in total addressable market, and the acquisition and integration of an active cutting-edge telehealth platform with a national customer footprint already established, and with the goal of uplisting to a major exchange, Progressive Care ( RXMD
Loading...
Loading...
) continues to aggressively strive toward leadership as an innovative technology and personalized healthcare company.”
Management also notes that, according to a recent report by Fortune Business Insights, the global telemedicine market is projected to grow from $34.28 billion in 2018 to $185.66 billion by 2026, exhibiting a CAGR of 23.5% over that period. Another report from Global Market Insights notes that nearly half of this overall market size and growth is attributable to activity within the US market alone. According to multiple market research publications, the mail-order prescription market is growing nearly twice as fast as any other segment of the prescription drug market.
For more information about Progressive Care ( RXMD
Loading...
Loading...
), please visit our website.
Connect and stay in touch with us on social media:
Progressive Care Inc. ( RXMD
Loading...
Loading...
)
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
Definitely a buyers market today! RXMD!
It won't take much to get to 7's.....
Ask is getting picked at nicely!
New CEO coming!
RXMD word starting to spread!
Been loaded for years! LOL!
Up 8% Starting to move.........
Thin....
MPID ASK PRICE SIZE TIME
ETRF 0.0475 74,033 10:47
ALPS 0.0475 10,000 10:34
CSTI 0.0489 94,000 10:28
CDEL 0.049 33,150 10:50
GTSM 0.0506 10,000 09/16
August number soon, S-1, Uplisting, New CEO.....lots of positives here!!!
L2 nice and thin!
Need $.30 or higher! RXMD!
This thing is due to go much higher!!!
Agreed!
They need to update us on the COVID tests and supplies on the next CC! Great that we are doing many things here!
Yesterday was a good teaser to what is really coming! Everyone holding on to their shares here!
This should be trading much much higher........
August numbers will be out shortly! YOY Records again I'm guessing...
Jump on in! Still a good buy in price....
Strongly Agree. Only a matter of time here.
I'd like to see 7's......
Patient Access Solutions Important Shareholder Notice: A Dividend Inclusion and Disbursement Clarification
BY GlobeNewswire
— 2:16 PM ET 09/16/2020
Commack, NY, Sept. 16, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Patient Access Solutions, Inc. , a provider of technology and management solutions for the healthcare and financial industries, offers clarification of the dividend disbursement.
It has come to our attention that many shareholders are looking for clarification on how the dividend will work. It is our intent to clarify that now, how and to whom it will be paid, as well as any question regarding the tender offer.
Both these actions involve the new Series C Convertible Preferred Stock. The first is a dividend to allshareholders of recordon September 18, 2020 at the close of the market. For every 5,000 shares of common stock then owned, each shareholder will receive one (1) Series C Convertible Preferred share. It is important to point out that to receive this dividend one must buy the stock no later than today. As a purchase done today settles on Friday the 18th; the shareholder of record date declared. The payment of the dividend will be processed as follows:
DTC, Depository Trust Company, will receive a block of Series C shares from the Transfer Agent so that these Series C shares can be distributed to the brokerage firms that hold the stock on behalf of all shareholders. Each brokerage firm will then automatically distribute the appropriate dividend to each shareholder’s account. Nothing needs to be done by any shareholder to receive the dividend. As there are only about 30% of our issued and outstanding shares deposited in the DTC system, 221,164,905 of the 749,993,098 respectively as of September 11th, many shareholders hold the physical shares, 6,187 shareholders hold the deposited shares. The shareholders holding physical shares need do nothing as well. Our transfer agent will be depositing those dividends directly into those accounts in book entry form right at the agent in each shareholder’s name.
The second item the Company has authorized is the tender offer for all common shareholders of record on the same date, September 18th. For each shareholder wishing to tender, exchange, their common shares for the new Series C Convertible Preferred stock the following covers the procedures. That conversion rate will be one (1) share of the new Preferred for every 250 shares of common owned. The deadline to tender is Friday September 18th. This will be processed as follows:
Should you decide to tender your shares, you must complete the attached “Tender Share Conversion” and deliver it to your brokerage firm for those shareholders whose stock is held at a brokerage firm. Upon execution, the shares must be returned to the Transfer Agent. This will be done entirely by your brokerage firm. The distribution of your new Series C shares will be then done by our Transfer Agent to each shareholder through your brokerage firm right into your account. For those shareholders that hold their stock in certificate form, you will be receiving a letter directly from our Transfer Agent instructing you how to tender your shares. Included in this mailing will be the form listed below in this release as well as each step required to complete the process.
Please use the following form to tender shares:
Don't forget August numbers coming!!! Love my investment here!
It's getting a lot of needed attention lately. Looking awesome here!
Only going to get bigger! Word is finally getting out how solid this company is....
CBTC NEWS SOON?!?!?!?!?!!?!?
Good Morning PASO!!!!
Ah! Ok...got it! Thanks! Markets shows bullish.....
What Does Your Post Even Mean? What????? Doesn't Pertain To RXMD....
I agree. Nice to see we are green also! People holding on for $$$$
I'm glad they put out this update. Then August numbers!